ArticleAlzheimer's & dementia (New York, N. Y.)2020
Validation of SATURN, a free, electronic, self-administered cognitive screening test.
Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Beyond expectations: nocebo suggestion affects cognitive performance in older adults.Psychological research · 2026Trial
- Retrospective validation of SATURN, a public domain self-administered cognitive screening test.Frontiers in psychology · 2026Article
- A brief checklist of modifiable dementia risk factors (RF12): associations with cognitive and affective measures in an Italian cohort.Frontiers in aging neuroscience · 2026Article
- A User-Centered Design Approach for a Screening App for People With Cognitive Impairment (digiDEM-SCREEN): Development and Usability Study.JMIR human factors · 2025Article
- Article
- The Potential of Automated Assessment of Cognitive Function Using Non-Neuroimaging Data: A Systematic Review.Journal of clinical medicine · 2024Review
- Normative study of SATURN: a digital, self-administered, open-source cognitive assessment tool for Italians aged 50-80.Frontiers in psychology · 2024Article
- The RODI mHealth app Insight: Machine-Learning-Driven Identification of Digital Indicators for Neurodegenerative Disorder Detection.Healthcare (Basel, Switzerland) · 2023Article
- Feasibility of Remote Unsupervised Cognitive Screening With SATURN in Older Adults.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2023Article
- Newly self-administered two-step tool for screening cognitive function in an ageing Chinese population: an exploratory cross-sectional study.General psychiatry · 2023Article
- Inferring Cognitive Abilities from Response Times to Web-Administered Survey Items in a Population-Representative Sample.Journal of Intelligence · 2022Article
- Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.Journal of clinical medicine · 2022Review
- Self-administered Web-Based Tests of Executive Functioning and Perceptual Speed: Measurement Development Study With a Large Probability-Based Survey Panel.Journal of medical Internet research · 2022Article
- Digital Phenotyping in Clinical Neurology.Seminars in neurology · 2022Article
- Validation of SATURN, a free, electronic, self-administered cognitive screening test.Alzheimer's & dementia (New York, N. Y.) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundCognitive screening is limited by clinician time and variability in administration and scoring. We therefore developed Self-Administered Tasks Uncovering Risk of Neurodegeneration (SATURN), a free, public-domain, self-administered, and automatically scored cognitive screening test, and validated it on inexpensive (<$100) computer tablets.
methodsSATURN is a 30-point test including orientation, word recall, and math items adapted from the Saint Louis University Mental Status test, modified versions of the Stroop and Trails tasks, and other assessments of visuospatial function and memory. English-speaking neurology clinic patients and their partners 50 to 89 years of age were given SATURN, the Montreal Cognitive Assessment (MoCA), and a brief survey about test preferences. For patients recruited from dementia clinics (n = 23), clinical status was quantified with the Clinical Dementia Rating (CDR) scale. Care partners (n = 37) were assigned CDR = 0.
resultsSATURN and MoCA scores were highly correlated ( DISCUSSION: Performance on SATURN-a fully self-administered and freely available (https://doi.org/10.5061/dryad.02v6wwpzr) cognitive screening test-is well-correlated with MoCA and CDR scores.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.